We are live on ! Find out more
NRD

Nebula Research & Development Portfolio holdings

AUM $1.17B
1-Year Est. Return 15.19%
This Fund
S&P 500
This Quarter Est. Return
+7.19%
1 Year Est. Return
+15.19%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$836M
AUM Growth
+$219M
Cap. Flow
+$188M
Cap. Flow %
22.5%
Top 10 Hldgs %
4.49%
Holding
1,220
New
441
Increased
247
Reduced
213
Closed
319

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.41M
2
AAP icon
Advance Auto Parts
AAP
+$4.15M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.96M
4
DLTR icon
Dollar Tree
DLTR
+$3.82M
5
MSFT icon
Microsoft
MSFT
+$3.74M

Top Sells

Rank Stock Value
1
BAC icon
Bank of America
BAC
+$2.82M
2
KO icon
Coca-Cola
KO
+$2.82M
3
GD icon
General Dynamics
GD
+$2.82M
4
ORCL icon
Oracle
ORCL
+$2.81M
5
HLNE icon
Hamilton Lane
HLNE
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Industrials 15.72%
3 Consumer Discretionary 15.68%
4 Healthcare 13.43%
5 Financials 10.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVDA icon
1
NVIDIA
NVDA
$4.76T
$3.78M 0.45%
31,091
+28,394
+1,053% +$3.35M
MU icon
2
Micron Technology
MU
$1.02T
$3.77M 0.45%
36,369
+27,679
+319% +$2.89M
MSFT icon
3
Microsoft
MSFT
$2.89T
$3.77M 0.45%
+8,758
New +$3.74M
ADSK icon
4
Autodesk
ADSK
$47.7B
$3.76M 0.45%
13,654
+10,245
+301% +$2.58M
ALL icon
5
Allstate
ALL
$67.3B
$3.76M 0.45%
+19,808
New +$3.52M
TJX icon
6
TJX Companies
TJX
$173B
$3.75M 0.45%
31,930
+29,308
+1,118% +$3.36M
V icon
7
Visa
V
$689B
$3.75M 0.45%
+13,637
New +$3.69M
WMT icon
8
Walmart Inc
WMT
$889B
$3.75M 0.45%
46,414
+28,338
+157% +$2.08M
TPR icon
9
Tapestry
TPR
$29.8B
$3.75M 0.45%
+79,719
New +$3.29M
TEAM icon
10
Atlassian
TEAM
$24.3B
$3.74M 0.45%
23,572
+16,384
+228% +$2.69M
REGN icon
11
Regeneron Pharmaceuticals
REGN
$69.9B
$3.74M 0.45%
+3,560
New +$3.96M
LRN icon
12
Stride
LRN
$3.83B
$3.74M 0.45%
+43,867
New +$3.39M
CTAS icon
13
Cintas
CTAS
$84.4B
$3.72M 0.45%
18,090
+13,734
+315% +$2.65M
BMRN icon
14
BioMarin Pharmaceuticals
BMRN
$11.6B
$3.7M 0.44%
+52,699
New +$4.41M
EPAM icon
15
EPAM Systems
EPAM
$4.92B
$3.67M 0.44%
18,439
+10,920
+145% +$2.19M
HIMS icon
16
Hims & Hers Health
HIMS
$7B
$3.63M 0.43%
196,814
+165,102
+521% +$2.96M
CEG icon
17
Constellation Energy
CEG
$96.4B
$3.59M 0.43%
13,825
+4,086
+42% +$812K
DTE icon
18
DTE Energy
DTE
$30.6B
$3.55M 0.42%
+27,655
New +$3.33M
LKQ icon
19
LKQ Corp
LKQ
$6.69B
$3.53M 0.42%
+88,366
New +$3.64M
AMZN icon
20
Amazon
AMZN
$2.49T
$3.46M 0.41%
18,549
+7,913
+74% +$1.44M
ONTO icon
21
Onto Innovation
ONTO
$13B
$3.45M 0.41%
16,610
+13,978
+531% +$2.82M
UAL icon
22
United Airlines
UAL
$39.1B
$3.4M 0.41%
59,607
+46,117
+342% +$2.13M
SHOO icon
23
Steven Madden
SHOO
$3.18B
$3.39M 0.41%
+69,291
New +$3.07M
PEGA icon
24
Pegasystems
PEGA
$4.7B
$3.35M 0.4%
91,694
+35,552
+63% +$1.17M
AAPL icon
25
Apple
AAPL
$4.95T
$3.34M 0.4%
14,341
+2,188
+18% +$489K
1
2 3 4 5

Similar funds

SAF
Smith Anglin Financial Dallas, Texas $1.1B AUM 14.08% 1-Year Est. Return
GIM
Grassi Investment Management Santa Clara, California $1.26B AUM 23.4% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
PP
PrairieView Partners St. Paul, Minnesota $1.03B AUM 11.4% 1-Year Est. Return
FC
Forte Capital Rochester, New York $930M AUM 24.11% 1-Year Est. Return
HIP
HPS Investment Partners New York $1.52B AUM 19.81% 1-Year Est. Return
SC
Savoie Capital Chicago, Illinois $805M AUM 19.48% 1-Year Est. Return
BWA
Bordeaux Wealth Advisors Menlo Park, California $781M AUM 26.55% 1-Year Est. Return

Nebula Research & Development's Q3 2024 Portfolio in Review

As of Q3 2024, Nebula Research & Development held 1,220 positions worth $836M, up 35% from $618M the previous quarter. Its ten largest holdings account for 4.5% of the portfolio.

Nebula Research & Development deployed $188M of net new capital in Q3 2024, opening 441 new positions and adding to 247 existing holdings. Its largest new stake was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was Travelers Companies, an estimated $2.39M trimmed.

  • Nebula Research & Development's largest Q3 2024 buy was BioMarin Pharmaceuticals: 52,699 shares worth $3.7M.
  • Nebula Research & Development added most to Dollar Tree in Q3 2024, an estimated $3.82M increase.
  • Nebula Research & Development's biggest Q3 2024 reduction was Travelers Companies, cutting an estimated $2.39M.
  • Nebula Research & Development fully exited Bank of America in Q3 2024, selling an estimated $2.82M.
  • Nebula Research & Development's ten largest holdings make up 4.5% of its $836M portfolio in Q3 2024.
  • Nebula Research & Development opened 441 new positions and closed 319 in Q3 2024.
  • Nebula Research & Development's portfolio value rose 35% quarter-over-quarter to $836M.

Based on Nebula Research & Development's 13F filing for Q3 2024, filed 14 Nov 2024.